pancreatic cancer debate: optimal therapy - adjuvant folfirinox
Published 5 years ago • 2.7K plays • Length 12:08Download video MP4
Download video MP3
Similar videos
-
8:43
debate: optimal adjuvant therapy for resected pancreatic cancer? - gem/nab-paclitaxel or folfirinox
-
7:54
pancreatic cancer debate: optimal therapy - preoperative chemo/chemoradiotherapy
-
8:31
debate: optimal therapy for patients with resectable pancreatic cancer - surgery plus adjuvant chemo
-
10:22
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - total neoadjuvant
-
5:23
debate: optimal therapy for patients with resectable pancreatic cancer - neoadjuvant chemotherapy
-
8:14
debate 9: optimal adjuvant therapy in pancreatic cancer? - intensified chemotherapy
-
10:50
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - adjuvant therapy
-
13:42
debate: optimal neoadjuvant strategy in pancreatic cancer - chemotherapy alone
-
8:06
debate 9: optimal adjuvant therapy in pancreatic cancer? - gemcitabine alone
-
10:48
debate: adjuvant treatment of pancreatic cancer - monotherapy
-
10:28
debate: treatment for resectable pancreatic cancer? - surgery adjuvant chemotherapy
-
8:46
debate: optimal chemotherapy backbone for targeted agents in pancreatic cancer? - folfirinox
-
14:02
debate: optimal neoadjuvant stategy in pancreatic cancer? - pre-operative chemotherapy radiation
-
10:56
debate: optimal adjuvant chemotherapy for resected pancreatic cancer - gemcitabine/capecitabine
-
10:52
debate: optimal neoadjuvant strategy in pancreatic cancer - preoperative chemotherapy radiation
-
2:30
#esmo21 highlights on gemcitabine vs mfolfirinox in resected pancreatic cancer: prodige 24/cctg pa6
-
1:38
nepafox: adjuvant gemcitabine vs. folfirinox in resectable pancreatic cancer
-
18:33
gemcitabine monotherapy vs. doublet therapy vs. folfirinox for metastatic pancreatic adenocarcinoma
-
9:06
debate: optimal adjuvant chemotherapy for resected pancreatic cancer - gemcitabine/nab-paclitaxel